ArticleFrontiers in endocrinology2026
Effect of weight loss intervention on assisted reproductive outcomes in women with obesity and infertility: a retrospective cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Risk factors and treatment strategies for live birth in women with high BMI undergoing ART.BMC medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This retrospective cohort study aimed to evaluate whether a goal-directed weight loss intervention prior to assisted reproductive technology (ART) improves live birth rates compared with immediate Methods: A total of 308 women with obesity and infertility who underwent ART at Yancheng Maternal and Child Health Hospital between January 2022 and June 2024 were included. After excluding those with missing covariates and performing 1:1 propensity score matching (PSM), 58 patients were assigned to the Target-oriented Group (comprehensive weight loss intervention, including low-calorie diet, physical activity enhancement, and orlistat (120 mg three times daily) as a pharmacological adjunct to reduce fat absorption, aiming to achieve an 8% weight reduction) and 58 to the Standard Lifestyle Group (general lifestyle advice without specific weight loss targets). Because the weight-loss program inherently delayed ART initiation by approximately 16 weeks, a 16-week landmark analysis was performed to align the exposure assessment window between groups and minimize immortal time bias; only women who remained under active follow-up and were event-free at week 16 were included in the analysis. Results: After 16 weeks, the Target-oriented Group achieved a mean weight reduction of 9.96% (standard deviation [SD] 9.40), whereas the Standard Lifestyle Group showed minimal change (0.68%, SD 2.07; P<0.001). The live birth rate was significantly higher in the Target-oriented Group (39.66%, 23/58) than in the Standard Lifestyle Group (15.52%, 9/58) (risk difference: 24.1%, 95% CI: 6.8-41.5%, Conclusion: Although this retrospective study design limits causal inference, a 16-week intensive goal-directed weight loss intervention appeared to be associated with both significant weight reduction and higher live birth rates among women with obesity and infertility, in comparison with immediate IVF without prior weight management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.